Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $431.30 million. The enterprise value is $333.35 million.

Market Cap	431.30M
Enterprise Value	333.35M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BNTC has 26.25 million shares outstanding. The number of shares has increased by 97.17% in one year.

Current Share Class	26.25M
Shares Outstanding	26.25M
Shares Change (YoY)	+97.17%
Shares Change (QoQ)	+6.63%
Owned by Insiders (%)	3.67%
Owned by Institutions (%)	45.63%
Float	13.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.36
P/TBV Ratio	4.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 54.67, with a Debt / Equity ratio of 0.01.

Current Ratio	54.67
Quick Ratio	54.26
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.46% and return on invested capital (ROIC) is -35.84%.

Return on Equity (ROE)	-52.46%
Return on Assets (ROA)	-34.39%
Return on Invested Capital (ROIC)	-35.84%
Return on Capital Employed (ROCE)	-42.71%
Revenue Per Employee	n/a
Profits Per Employee	-$2.00M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.76% in the last 52 weeks. The beta is 0.41, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+45.76%
50-Day Moving Average	14.21
200-Day Moving Average	13.24
Relative Strength Index (RSI)	56.39
Average Volume (20 Days)	62,712

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.77M
Pretax Income	-37.92M
Net Income	-37.92M
EBITDA	-41.70M
EBIT	-41.77M
Earnings Per Share (EPS)	-$1.05

Balance Sheet

The company has $97.74 million in cash and $849,000 in debt, giving a net cash position of $96.90 million or $3.69 per share.

Cash & Cash Equivalents	97.74M
Total Debt	849,000
Net Cash	96.90M
Net Cash Per Share	$3.69
Equity (Book Value)	97.30M
Book Value Per Share	3.71
Working Capital	96.72M

Cash Flow

In the last 12 months, operating cash flow was -$23.59 million and capital expenditures -$18,000, giving a free cash flow of -$23.61 million.

Operating Cash Flow	-23.59M
Capital Expenditures	-18,000
Free Cash Flow	-23.61M
FCF Per Share	-$0.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.17%
Shareholder Yield	-97.17%
Earnings Yield	-8.81%
FCF Yield	-5.49%

Analyst Forecast

The average price target for BNTC is $24.80, which is 50.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.80
Price Target Difference	50.94%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	2